AFT Pharmaceuticals Ltd. (AU:AFP) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Andrew Lane, a director at AFT Pharmaceuticals, has made a significant move in the stock market by acquiring 95,000 ordinary shares in the company, valued at approximately $257,500. This on-market purchase reflects Lane’s growing interest in AFT’s future prospects, attracting attention from investors keen on stock market developments.
For further insights into AU:AFP stock, check out TipRanks’ Stock Analysis page.